Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-344304
Filing Date
2015-10-15
Accepted
2015-10-15 09:18:00
Documents
5
Effectiveness Date
2015-10-15

Document Format Files

Seq Description Document Type Size
1 DEFA 14A d51563ddefa14a.htm DEFA14A 24818
2 GRAPHIC g51563notice_p1.jpg GRAPHIC 71390
3 GRAPHIC g51563notice_p2.jpg GRAPHIC 124888
4 GRAPHIC g51563notice_p3.jpg GRAPHIC 44178
5 GRAPHIC g51563notice_p4.jpg GRAPHIC 10477
  Complete submission text file 0001193125-15-344304.txt   349100
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 151159311
SIC: 2835 In Vitro & In Vivo Diagnostic Substances